EU Business Round-Up: ColdZyme Heading To MENA, Kerry Expands Probiotics Offering, Galenica Launches Vita-Merfen
Executive Summary
Latest EU company news: Enymatica strikes deal to take its ColdZyme common cold product into MENA; Ireland's Kerry snaps up Canadian probiotics specialist Bio-K Plus; and Switerland's Galenica relaunches Vita-Merfen after a five-year absence.
You may also be interested in...
Euro Results Round-Up: Galenica, Recordati And Karo Pharma
The latest Q2 and first-half financial results from European consumer health players. Featuring Switzerland's Galenica, Italy's Recordati and Sweden's Karo Pharma.
EU Probiotics News: Strong Year For Probi, BioGaia Struggles, Kerry Targets Biosearch Deal
Latest European Probiotics News: Probi and BioGaia post earnings, with differing results, while Kerry seeks to expand with Spain's Biosearch.
UK Proposes Accelerating Authorizations Of Novel Supplements Like CBD
UK Food Standards Agency proposes shaving a minimum of three months off novel food authorization procedure as part of wider plans to shake-up the process for products like CBD supplements.